RESEARCH PAPER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Increased taxation is one of the most effective tobacco control measures. Price differentials across tobacco product types may undermine the effectiveness of taxation policies by providing the option to switch to cheaper products rather than to quit. The aim of this study was to use commercial data to compare prices and price differentials of both cigarette and non-cigarette products across countries from all geographical regions.

Methods:
We analyzed 6920 price data points (i.e. product brands) from Euromonitor Passport 2016 for 12 types of tobacco products across 79 countries from the six WHO regions: Africa (n=5), Eastern Mediterranean (n=6), Europe (n=39), the Americas (n=15), South-East Asia (n=3), and Western Pacific (n=12). For each product and country, a price differential was computed as the percentage of minimum price to the median.

Results:
Median cigarette prices (US$) were highest in Western Pacific countries (4.00; range: 0.80–16.20) and European countries (3.80; range: 0.80–14.00), but lowest in African countries (2.00; range: 0.80–2.20). The medians of cigarette price differentials were largest in the Eastern Mediterranean (48.33%) and African regions (50.00%), but smallest in Europe (82.35%). Pipe tobacco and fine-cut tobacco were generally less expensive than cigarettes while cigars were the most expensive. However, there were wide variations in prices and price differentials across regions and tobacco products.

Conclusions:
We found substantial variations in prices and price differentials between countries and world regions across tobacco products, likely reflecting differences in taxation policies and structures. Findings identify types of tobacco products in specific geographical regions where price differentials are highest, thereby highlighting areas where taxation policies need improvement, for example through implementing specific excise taxes.

CONFLICTS OF INTEREST
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
FUNDING
There was no source of funding for this research.
ETHICAL APPROVAL AND INFORMED CONSENT
Ethical approval and informed consent were not required for this study given that the dataset consisted of aggregate anonymized data and did not involve human subjects.
DATA AVAILABILITY
Data sharing is not applicable to this article as no new data were created.
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
 
REFERENCES (40)
1.
World Health Organization. WHO Report on the Global Tobacco Epidemic, 2021: Addressing new and emerging products. World Health Organization; 2021. Accessed July 7, 2021. https://apps.who.int/iris/bits...
 
2.
World Health Organization. WHO Report on The Global Tobacco Epidemic, 2008. The MPOWER Package. World Health Organization; 2008. Accessed July 7, 2021.https://apps.who.int/iris/bits...
 
3.
WHO Framework Convention on Tobacco Control. Guidelines for the Implementation of Article 6 of the WHO FCTC. Accessed July 7, 2021. https://www.who.int/fctc/guide...
 
4.
International Agency for Research on Cancer. Effectiveness of Tax and Price Policies for Tobacco Control. International Agency for Research on Cancer; 2011. IARC Handbooks of Cancer Prevention; vol 14.
 
5.
Partos TR, Hiscock R, Gilmore AB, Branston JR, Hitchman S, McNeill A. Impact of Tobacco Tax Increases and Industry Pricing on Smoking Behaviours and Inequalities: A Mixed-Methods Study. NIHR Journals Library; 2020. doi:10.3310/phr08060.
 
6.
He Y, Shang C, Chaloupka FJ. The association between cigarette affordability and consumption: An update. PLoS One. 2018;13(12):e0200665. doi:10.1371/journal.pone.0200665.
 
7.
Chung-Hall J, Craig L, Gravely S, Sansone N, Fong GT. Impact of the WHO FCTC over the first decade: A global evidence review prepared for the Impact Assessment Expert Group. Tob Control. 2019;28. doi:10.1136/tobaccocontrol-2018-054389.
 
8.
Hiscock R, Branston JR, McNeill A, Hitchman SC, Partos TR, Gilmore AB. Tobacco industry strategies undermine government tax policy: evidence from commercial data. Tob Control. 2018;27(5):488-497. doi:10.1136/tobaccocontrol-2017-053891.
 
9.
Partos TR, Gilmore AB, Hitchman SC, Hiscock R, Branston JR, McNeill A. Availability and Use of Cheap Tobacco in the United Kingdom 2002-2014: Findings From the International Tobacco Control Project. Nicotine Tob Res. 2018;20(6):714-724. doi:10.1093/ntr/ntx108.
 
10.
Licht AS, Hyland AJ, O’Connor RJ, et al. How do price minimizing behaviors impact smoking cessation? Findings from the International Tobacco Control (ITC) Four Country Survey. Int J Environ Res Public Health. 2011;8(5):1671-1691. doi:10.3390/ijerph8051671
 
11.
World Health Organization. WHO Technical Manual on Tobacco Tax Administration. World Health Organization; 2010.
 
12.
Agaku IT, Alpert HR. Trends in annual sales and current use of cigarettes, cigars, roll-your-own tobacco, pipes, and smokeless tobacco among US adults, 2002-2012. Tob Control. 2016;25(4):451-457. doi:10.1136/tobaccocontrol-2014-052125
 
13.
Zaatari GS, Bazzi A. Impact of the WHO FCTC on non-cigarette tobacco products. Tob Control. 2019;28(Suppl 2):s104-s112. doi:10.1136/tobaccocontrol-2018-054346.
 
14.
Siddiqi K, Shah S, Abbas SM, et al. Global burden of disease due to smokeless tobacco consumption in adults: analysis of data from 113 countries. BMC Med. 2015;13:194. doi:10.1186/s12916-015-0424-2.
 
15.
Blecher EH, van Walbeek CP. Cigarette affordability trends: an update and some methodological comments. Tob Control. 2009;18(3):167-175. doi:10.1136/tc.2008.026682.
 
16.
Jawad M, Lee JT, Glantz S, Millett C. Price elasticity of demand of non-cigarette tobacco products: a systematic review and meta-analysis. Tob Control. 2018;27(6):689-695. doi:10.1136/tobaccocontrol-2017-054056.
 
17.
Euromonitor International. Passport. Accessed June 2, 2021. https://go.euromonitor.com/pas...
 
18.
Filippidis FT, Laverty AA, Hone T, Been J V, Millett C. Association of Cigarette Price Differentials With Infant Mortality in 23 European Union Countries. JAMA Pediatr. 2017;171(11):1100-1106. doi:10.1001/jamapediatrics.2017.2536.
 
19.
Evans-Reeves KA, Hiscock R, Lauber K, Gilmore AB. Prospective longitudinal study of tobacco company adaptation to standardised packaging in the UK: identifying circumventions and closing loopholes. BMJ Open. 2019;9(9):e028506. doi:10.1136/bmjopen-2018-028506.
 
20.
Laverty AA, Millett C, Filippidis FT. Associations between cigarette prices and consumption in Europe 2004-2014. Tob Control. 2021;30(1):111-113. doi:10.1136/tobaccocontrol-2019-055299.
 
21.
Gallagher AWA, Gilmore AB. Euromonitor international now accepts tobacco industry funding: a win for PMI at the expense of research on the tobacco industry. Tobacco Control Blog; 2019. Accessed September 20, 2021. https://blogs.bmj.com/tc/2019/...
 
22.
Mcneill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes : an evidence update. A report commissioned by Public Health England. Public Health England; 2015:111. Accessed July 7, 2021. www.gov.uk/government/uploads/...
 
23.
Australian Government - Department of Health. Ingredients in different Marlboro varieties. Accessed June 6, 2020. https://www1.health.gov.au/int...
 
24.
NHS Scotland. Module 4: Products to Support Smoking Cessation Attempts. Working out cigarette equivalents. Accessed June 6, 2020. http://www.smoking2.nes.scot.n...
 
25.
NIH National Cancer Institute. Cigar Smoking and Cancer. Accessed June 6, 2020. https://www.cancer.gov/about-c...
 
26.
Minardi V, Ferrante G, D’Argenio P, et al. Roll-your-own cigarette use in Italy: sales and consumer profile—data from PASSI surveillance, 2015–2016. Int J Public Health. 2019;64(3). doi:10.1007/s00038-019-01204-5.
 
27.
Schaller JP, Keller D, Poget L, et al. Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul Toxicol Pharmacol. 2016;81 Suppl 2:S27-S47. doi:10.1016/j.yrtph.2016.10.001.
 
28.
Simonavicius E, McNeill A, Shahab L, Brose LS. Heat-not-burn tobacco products: a systematic literature review. Tob Control. 2019;28(5):582-594. doi:10.1136/tobaccocontrol-2018-054419.
 
29.
Cullen D, Keithly L, Kane K, et al. Smokeless tobacco products sold in Massachusetts from 2003 to 2012: trends and variations in brand availability, nicotine contents and design features. Tob Control. 2015;24(3):256-262. doi:10.1136/tobaccocontrol-2013-051225.
 
30.
World Health Organization. Country groupings. Accessed October 11, 2021. https://www.who.int/observator...
 
31.
European Parliament and the Council of the European Union. Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC. Official Journal of the European Union. 2014;L127:1-38. Accessed July 7, 2021. https://ec.europa.eu/health/si...
 
32.
Filippidis FT, Mechili EA, Girvalaki C, Vardavas C. Cost, prevalence and correlates of cigarillo use in 28 European countries in 2017. Cent Eur J Public Health. 2019;27(3):182-187. doi:10.21101/cejph.a5583.
 
33.
John RM, Dauchy E. Trends in affordability of tobacco products before and after the transition to GST in India. Tob Control. 2020;30. doi:10.1136/tobaccocontrol-2019-055525.
 
34.
Nargis N, Stoklosa M, Drope J, et al. Trend in the affordability of tobacco products in Bangladesh: findings from the ITC Bangladesh Surveys. Tob Control. 2019;28(Suppl 1):s20-s30. doi:10.1136/tobaccocontrol-2017-054035.
 
35.
National Cancer Institute, World Health Organization. The Economics of Tobacco and Tobacco Control. National Cancer Institute, World Health Organization; 2016. NCI Tobacco Control Monograph; vol 21. Accessed July 7, 2021. https://cancercontrol.cancer.g...
 
36.
Chaloupka FJ, Sweanor D, Warner KE. Differential Taxes for Differential Risks — Toward Reduced Harm from Nicotine-Yielding Products. N Engl J Med. 2015;373(7):594-597. doi:10.1056/NEJMp1505710.
 
37.
Chaloupka FJ, Kostova D, Shang C. Cigarette excise tax structure and cigarette prices: evidence from the global adult tobacco survey and the U.S. National Adult Tobacco Survey. Nicotine Tob Res. 2014;16 Suppl 1:S3-S9. doi:10.1093/ntr/ntt121.
 
38.
Husain MJ, Kostova D, Mbulo L, Benjakul S, Kengganpanich M, Andes L. Changes in cigarette prices, affordability, and brand-tier consumption after a tobacco tax increase in Thailand: Evidence from the Global Adult Tobacco Surveys, 2009 and 2011. Prev Med. 2017;105S:S4-S9. doi:10.1016/j.ypmed.2017.05.027.
 
39.
Gallus S, Lugo A, Ghislandi S, La Vecchia C, Gilmore AB. Roll-your-own cigarettes in Europe: Use, weight and implications for fiscal policies. Eur J Cancer Prev. 2014;23(3). doi:10.1097/CEJ.0000000000000010
 
40.
Branston JR, Hiscock R, Silver K, Arnott D, Gilmore AB. Cigarette-like cigarillo introduced to bypass taxation, standardised packaging, minimum pack sizes, and menthol ban in the UK. Tob Control. 2020. doi:10.1136/tobaccocontrol-2020-055700.
 
eISSN:1617-9625